Detalhe da pesquisa
1.
Chimpanzee Adenovirus Vector Ebola Vaccine.
N Engl J Med
; 376(10): 928-938, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25426834
2.
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
Proc Natl Acad Sci U S A
; 114(10): 2711-2716, 2017 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28223498
3.
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial.
Lancet
; 385(9977): 1545-54, 2015 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25540891
4.
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
N Engl J Med
; 369(22): 2083-92, 2013 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24099601
5.
Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial.
J Infect Dis
; 211(4): 549-57, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25225676
6.
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.
Lancet
; 384(9959): 2046-52, 2014 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132507
7.
Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect.
J Infect Dis
; 208(3): 418-22, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23633407
8.
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.
J Infect Dis
; 207(12): 1829-40, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23482645
9.
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.
J Infect Dis
; 203(10): 1396-404, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21398392
10.
Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.
PLoS One
; 14(9): e0222178, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31532789
11.
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
PLoS One
; 13(11): e0206837, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30388160
12.
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.
NPJ Vaccines
; 2: 15, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263871
13.
Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).
PLoS One
; 11(11): e0166393, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27846256
14.
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.
Nat Med
; 22(6): 614-23, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27158907
15.
Phase 1 study of pandemic H1 DNA vaccine in healthy adults.
PLoS One
; 10(4): e0123969, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25884189
16.
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.
Contemp Clin Trials
; 44: 112-118, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275339
17.
DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial.
PLoS One
; 10(5): e0125914, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25950433
18.
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.
Sci Transl Med
; 7(319): 319ra206, 2015 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26702094
19.
Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial.
PLoS One
; 9(9): e106240, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25264782
20.
Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011).
PLoS One
; 9(3): e91366, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24621858